To mark this week’s second Biotech Future Forum in Belgrade, our CEO, Kiren L. Naidoo, reaffirms Zdravlje’s commitment to building the biotechnology industry in Serbia. Through valuable partnerships with the Government of the Republic of Serbia, academia, and leading international partners, Frontier Biopharma and Zdravlje are set to lead the biotechnology industry in the region across critical areas such as next-generation vaccines, cell & gene therapies – all domestically produced and intended to serve patients locally and abroad.
In line with this mission, we are dedicated to promoting Serbia as a hub for biotechnological innovation and manufacturing excellence. As we move forward, we remain committed to this transformative journey, firmly believing that by nurturing a thriving biotechnology sector in Serbia, we can create a healthier and more prosperous future for all. This demonstrates our long-term commitment to advancing science and improving health, and we’re thrilled to be at the forefront of these exciting developments.
Please follow the link below to view our CEO’s message.